Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Reports In Vivo Data Published in the Peer Reviewed, International Journal of Molecular Sciences, Indicating Prolonged Release of Amino Acids Using Its Physiomimic™ Technology May Have Benefits for the Treatment of PKU

https://relieftherapeutics.com/news-and-events

What can AVIPTADIL do for you???

VIP stimulates contractility in the heart, causes vasodilation, increases glycogenolysis, lowers arterial blood pressure and relaxes the smooth muscle of trachea, stomach and gallbladder. In humans, the vasoactive intestinal peptide is encoded by the VIP gene. ~ Wiki